Novel therapeutic strategies for recurrent SCLC
Moliner, Laura Zhang, B. Lamberti, G. Ardizzoni, A. Byers, L. A. Califano, Raffaele
Moliner, Laura
Zhang, B.
Lamberti, G.
Ardizzoni, A.
Byers, L. A.
Califano, Raffaele
Citations
Altmetric:
Abstract
Therapeutic options for patients with relapsed SCLC are limited, and the prognosis in this setting remains poor. While clinical outcomes for frontline treatment have modestly improved with the introduction of immunotherapy, treatment in the second-line setting persists almost unchanged. In this review, current treatment options and recent advances in molecular biology are described. Emerging therapeutic options in this setting, and potential strategies to improve clinical outcomes of these patients are also addressed.
Description
Date
2023
Publisher
Collections
Keywords
Type
Article
Citation
Moliner L, Zhang B, Lamberti G, Ardizzoni A, Byers LA, Califano R. Novel therapeutic strategies for recurrent SCLC. Crit Rev Oncol Hematol. 2023 Jun;186:104017. PubMed PMID: 37150311. Epub 2023/05/08. eng.